Keywords: cephalon, pays, 30m, rights, sle, drug, uk

Cephalon pays $30M for rights to SLE drug

Article | 09 February 2009

UK drug developer ImmuPharma has received $30.0 million from Cephalon as part of a global licensing agreement for systemic lupus erythromatosus ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Cephalon

Go to company listing